MDSS EUROPEAN AUTHORIZED REPRESENTATIVE SERVICES MDSS CONSULTANCY   ENGLISH    GERMAN

Get a Quote from MDSS Your Authorized Representative forMedical Devices and In Vitro Diagnostic Devices

News Updates
  • Looking for a suitable GMDN-Code?
    MDSS can assist you to determine an appropriate code for your products!
    more


  • Have MDSS, your Authorized Representative, apply for a Certificate of Marketability on your behalf! more


  • Update to IVD Directive... more

  • Update to MEDDEV Guidelines... more

  • Update to Portuguese Registration... more

  • Update to Vigilance Guideline... more

  • Italian Ministry of Health abolished 100€ fee.. more

  • Update on National Drug and Health Products Safety Agency.. more

    
HIGHLIGHTS
July 15 - 19, 2012
2012 AACC Clinical Lab Expo
Booth: tbd
Los Angeles, CA
United States




Oct. 26 - 30, 2012 

2012 RAPS
Annual Conference & Exhibition
Booth: #331
Seattle, WA
United States




Contact MDSS

MDSS GmbH
Schiffgraben 41
30175 Hannover
Germany

Phone
(+49)-511-6262 8630
FAX
(+49) -511-6262 8633

Click here to
contact us




Download Station

Medical Device Directive MDD93/42/EEC

The Medical Device Directive was published in 1993 by the European Commission. Medical device manufacturers were able to apply the Medical Device Directive on January 1, 1995. At that time, the manufacturers had the choice to apply either national regulation or the Medical Device Directive. In June 1998, the Directive became mandatory and medical devices, which fell under the scope of the Medical Device Directive, were no longer allowed without the CE mark on the European market. At that time, the European market consisted of 15 member states and countries of the European Economy Area (EEA). Today the EU has 27 member states and forms together with the EEA countries and Switzerland one single market, made up of 31 states.

The Medical Device Directive was corrected and amended over the time. There were only minor corrections, but some significant amendments. The amendments are being done either by including those into other directives, for example in the In-Vitro-Diagnostic Medical Device Directive, or by means of a separate document which covers a specific aspect, for example, the Directive 2000/70/EC of the European Parliament and the Council of November 16, 2000, amending Council Directive 93/42/EEC as regards medical devices incorporating stable derivatives of human blood or human plasma.

Please find the latest consolidated MDD93/42 EEC below, with the biggest change in 2007 which came into force in national legislation of the member states on March 21, 2010.

(Right click on the link below to download to your computer - select 'save target as')

MDD 93/42/ EEC in PDF format
 
(Status: June 2011)